semaglutide hospitalizations Effect of on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial Semaglutide reduced risks of infection SAEs, hospitalization due to infection, and all-cause death with greater benefit Oral Semaglutide and Cardiovascular Outcomes

The Bottom Line Large new studies suggest that people with Type 2 diabetes who take semaglutide may be less likely to develop dementia but current evidence does not prove cause and effect

:

The Precision Peptide Genetic Test ($99 add-on after month one) analyzes variants like GLP1R rs6923761 that influence GLP-1 receptor sensitivity and function

Sleep matters more than people expect

GSH, a potent scavenger of lipid peroxides, is a crucial cofactor for the selenoenzyme glutathione peroxidase 4 (GPX4), which effectively reverses phospholipid peroxidation and protects cells from ferroptosis (Stockwell et al., 2017a)